Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

168.12
Delayed Data
As of May 27
 +2.18 / +1.31%
Today’s Change
150.06
Today|||52-Week Range
203.30
-9.14%
Year-to-Date

Today’s Trading

Previous close165.94
Today’s open166.84
Day’s range-- - --
Volume1,605,813
Average volume (3 months)1,776,164
Market cap$33.1B
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+0.23%
Earnings growth (next 5 years)+21.56%
Revenue growth (last year)+46.49%
P/E ratio57.6
Price/Sales16.55
Price/Book10.00

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+1.49+2.11%
VRTXVertex Pharmaceutica...+5.17+4.22%
PRGOPerrigo Company PLC-1.25-0.64%
ZTSZoetis Inc+1.50+3.13%
Data as of 05/27/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.38
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers